A team led by chemist Frank Glorius, a professor at the Institute of Organic Chemistry at the University of Münster, has ...
AstraZeneca (AZN 5.74%) fell over 8% ahead of the opening bell after a late-stage clinical trial for its heart disease drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results